日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer

基于系列活检的转移性乳腺癌演变过程的组学和多维空间图谱

Brett E Johnson ,Allison L Creason ,Jayne M Stommel ,Jamie M Keck ,Swapnil Parmar ,Courtney B Betts ,Aurora Blucher ,Christopher Boniface ,Elmar Bucher ,Erik Burlingame ,Todd Camp ,Koei Chin ,Jennifer Eng ,Joseph Estabrook ,Heidi S Feiler ,Michael B Heskett ,Zhi Hu ,Annette Kolodzie ,Ben L Kong ,Marilyne Labrie ,Jinho Lee ,Patrick Leyshock ,Souraya Mitri ,Janice Patterson ,Jessica L Riesterer ,Shamilene Sivagnanam ,Julia Somers ,Damir Sudar ,Guillaume Thibault ,Benjamin R Weeder ,Christina Zheng ,Xiaolin Nan ,Reid F Thompson ,Laura M Heiser ,Paul T Spellman ,George Thomas ,Emek Demir ,Young Hwan Chang ,Lisa M Coussens ,Alexander R Guimaraes ,Christopher Corless ,Jeremy Goecks ,Raymond Bergan ,Zahi Mitri ,Gordon B Mills ,Joe W Gray

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)

细胞周期基因的基因组畸变可预测 KIT 突变型胃肠道间质瘤 (GIST) 的进展

Michael C Heinrich #, Janice Patterson #, Carol Beadling, Yuexiang Wang, Maria Debiec-Rychter, Barbara Dewaele, Christopher L Corless, Anette Duensing, Chandrajit P Raut, Brian Rubin, Tamas Ordog, Matt van de Rijn, Jerry Call, Thomas Mühlenberg, Jonathan A Fletcher #, Sebastian Bauer #1

Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity

KIT 突变肥大细胞的联合治疗:靶向组成型 NFAT 和 KIT 活性

Alison C Macleod, Lillian R Klug, Janice Patterson, Diana J Griffith, Carol Beadling, Ajia Town, Michael C Heinrich

Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors

索拉非尼可抑制与耐药性胃肠道间质瘤相关的多种激酶突变

Michael C Heinrich, Adrian Marino-Enriquez, Ajia Presnell, Rachel S Donsky, Diana J Griffith, Arin McKinley, Janice Patterson, Takahiro Taguchi, Cher-Wei Liang, Jonathan A Fletcher